“Johnson & Johnson on Tuesday said it has begun testing its Ebola-virus vaccine in humans and will have more than 400,000 doses available in April.”
Source: J&J Begins Human Testing of Ebola-Virus Vaccine – WSJ
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.